Fotemustine

Chemical compound
  • AU: D
ATC code
  • L01AD05 (WHO)
Legal statusLegal status
  • AU: S4 (Prescription only)
Identifiers
  • (RS)-diethyl (1-{[(2-chloroethyl)(nitroso)carbamoyl]amino}
    ethyl)phosphonate
CAS Number
  • 92118-27-9 ☒N
PubChem CID
  • 104799
DrugBank
  • DB04106 ☒N
ChemSpider
  • 94600 checkY
UNII
  • GQ7JL9P5I2
KEGG
  • D07255 checkY
ChEMBL
  • ChEMBL549386 checkY
CompTox Dashboard (EPA)
  • DTXSID80869091 Edit this at Wikidata
ECHA InfoCard100.158.792 Edit this at WikidataChemical and physical dataFormulaC9H19ClN3O5PMolar mass315.69 g·mol−13D model (JSmol)
  • Interactive image
  • O=P(OCC)(OCC)C(NC(=O)N(N=O)CCCl)C
InChI
  • InChI=1S/C9H19ClN3O5P/c1-4-17-19(16,18-5-2)8(3)11-9(14)13(12-15)7-6-10/h8H,4-7H2,1-3H3,(H,11,14) checkY
  • Key:YAKWPXVTIGTRJH-UHFFFAOYSA-N checkY
 ☒NcheckY (what is this?)  (verify)

Fotemustine is a nitrosourea alkylating agent used in the treatment of metastatic melanoma. It is available in Europe but has not been approved by the United States FDA.[1] A study[2] has shown that fotemustine produces improved response rates and but does not increase survival (over dacarbazine in the treatment of disseminated cutaneous melanoma. Median survival was 7.3 months with fotemustine versus 5.6 months with DTIC (P=.067). There was also toxicity prevalence in fotemustine arm. The main toxicity was grade 3 to 4 neutropenia (51% with fotemustine v 5% with DTIC) and thrombocytopenia (43% v 6%, respectively).

External links

  1. ^ Menaa, Farid (2013). "Latest Approved Therapies for Metastatic Melanoma: What Comes Next?". Journal of Skin Cancer. 2013: 1–10. doi:10.1155/2013/735282. PMC 3595667. PMID 23533766.
  2. ^ Avril MF, Aamdal S, Grob JJ, Hauschild A, Mohr P, Bonerandi JJ, Weichenthal M (March 2004). "Fotemustine Compared With Dacarbazine in Patients With Disseminated Malignant Melanoma: A Phase III Study". Journal of Clinical Oncology. 22 (6): 1118–25. doi:10.1200/JCO.2004.04.165. PMID 15020614.
  • v
  • t
  • e
SPs/MIs
(M phase)
Block microtubule assembly
Block microtubule disassembly
DNA replication
inhibitor
DNA precursors/
antimetabolites
(S phase)
Folic acid
Purine
Pyrimidine
Deoxyribonucleotide
Topoisomerase inhibitors
(S phase)
I
II
II+Intercalation
Crosslinking of DNA
(CCNS)
Alkylating
Platinum-based
Nonclassical
Intercalation
Photosensitizers/PDTOther
Enzyme inhibitors
Receptor antagonists
Other/ungrouped
Stub icon

This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it.

  • v
  • t
  • e